And now for the lawsuits: Forest shareholders revolt
This article was originally published in Scrip
The directors of Forest Laboratories have been ordered to appear in the New York Supreme Court after a shareholder launched legal action accusing its board of failing in their fiduciary duties, wasting corporate assets, allowing unjust enrichment and other violations.
You may also be interested in...
BioNTech extends Pfizer partnership to cover COVID-19 vaccine development and distribution while Fosun Pharma takes Chinese rights.
Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.
Infographic: Scrip homes in on key figures for companies integrating major acquisitions or divesting significant parts of their business.